2 Year Absolute Returns
35.33% ↑
NAV (₹) on 06 Apr 2026
16.85
1 Day NAV Change
0.57%
Risk Level
Very High Risk
Rating
-
HDFC Pharma and Healthcare Fund is a Equity mutual fund categorized under Sector, offered by HDFC Asset Management Company Ltd.. Launched on 14 Sep 2023, investors can start with a minimum SIP of ₹100 ... Read more
AUM
₹ 2,030.81 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 68.51% |
| Hospitals & Medical Services | 29.10% |
| Money Market Instruments | 1.88% |
| Medical Equipment & Accessories | 0.61% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 9.81% | ₹ 199.24 | Pharmaceuticals |
| Divis Laboratories Ltd. | 8.38% | ₹ 170.18 | Pharmaceuticals |
| Glenmark Pharmaceuticals Ltd. | 6.62% | ₹ 134.36 | Pharmaceuticals |
| Lupin Ltd. | 6.44% | ₹ 130.81 | Pharmaceuticals |
| Max Healthcare Institute Limited | 6.36% | ₹ 129.14 | Hospitals & Medical Services |
| Alkem Laboratories Ltd. | 6.21% | ₹ 126.04 | Pharmaceuticals |
| Aster DM Healthcare Limited | 5.42% | ₹ 110.04 | Hospitals & Medical Services |
| Ipca Laboratories Ltd. | 4.80% | ₹ 97.43 | Pharmaceuticals |
| Anthem Biosciences Limited | 4.46% | ₹ 90.58 | Pharmaceuticals |
| Fortis Healthcare Limited | 4.02% | ₹ 81.72 | Hospitals & Medical Services |
| Krishna Institute Of Medical Sciences Limited | 3.61% | ₹ 73.36 | Hospitals & Medical Services |
| Acutaas Chemicals Limited | 3.60% | ₹ 73.19 | Pharmaceuticals |
| Laurus Labs Ltd. | 2.91% | ₹ 59.10 | Pharmaceuticals |
| Metropolis Healthcare Ltd. | 2.53% | ₹ 51.47 | Hospitals & Medical Services |
| Torrent Pharmaceuticals Ltd. | 2.34% | ₹ 47.60 | Pharmaceuticals |
| Vijaya Diagnostic Centre Limited | 2.30% | ₹ 46.62 | Hospitals & Medical Services |
| Eris Lifesciences Ltd | 2.28% | ₹ 46.36 | Pharmaceuticals |
| Sai Life Sciences Limited | 2.09% | ₹ 42.52 | Pharmaceuticals |
| TREPS - Tri-party Repo | 1.88% | ₹ 38.16 | Others |
| Global Health Limited | 1.84% | ₹ 37.39 | Hospitals & Medical Services |
| Wockhardt Ltd. | 1.73% | ₹ 35.17 | Pharmaceuticals |
| Shilpa Medicare Ltd | 1.68% | ₹ 34.03 | Pharmaceuticals |
| Dr. Lal Path Labs Ltd | 1.63% | ₹ 33.03 | Hospitals & Medical Services |
| Thyrocare Technologies Ltd. | 1.39% | ₹ 28.31 | Hospitals & Medical Services |
| Jubilant Pharmova Limited | 1.35% | ₹ 27.51 | Pharmaceuticals |
| Rubicon Research Limited | 1.22% | ₹ 24.75 | Pharmaceuticals |
| Gland Pharma Ltd. | 1.12% | ₹ 22.82 | Pharmaceuticals |
| BAJAJ HEALTHCARE LIMITED | 0.92% | ₹ 18.75 | Pharmaceuticals |
| Laxmi Dental Limited | 0.61% | ₹ 12.41 | Medical Equipment & Accessories |
| CORONA REMEDIES LIMITED | 0.55% | ₹ 11.21 | Pharmaceuticals |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | -1.48% | 9.20% | 16.33% | - |
| Category returns | -6.29% | 4.17% | 4.66% | 20.68% |
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
HDFC Value Fund - Regular Plan
MidsmallCap
Regular
|
₹32.30 | 5.63% | 33.10% | 38.25% | ₹7,413 | 1.84% |
Very High
|
|
HDFC Value Fund - Regular Plan
MidsmallCap
Regular
|
₹32.30 | 5.63% | 33.10% | 38.25% | ₹7,413 | 1.84% |
Very High
|
|
HDFC Flexi Cap Fund - Direct Plan
Diversified
Direct
|
₹83.15 | -3.91% | 32.99% | 59.78% | ₹1,00,455 | 0.70% |
Very High
|
|
HDFC Flexi Cap Fund - Direct Plan
Diversified
Direct
|
₹83.15 | -3.91% | 32.99% | 59.78% | ₹1,00,455 | 0.70% |
Very High
|
|
HDFC Dividend Yield Fund - Direct Plan
Diversified
Direct
|
₹19.76 | -4.24% | 32.93% | 80.40% | ₹5,853 | 0.78% |
Very High
|
|
HDFC Dividend Yield Fund - Direct Plan
Diversified
Direct
|
₹19.76 | -4.24% | 32.93% | 80.40% | ₹5,853 | 0.78% |
Very High
|
|
HDFC Equity Savings Fund - Direct Plan
Hybrid
Direct
|
₹73.73 | 4.86% | 32.79% | 60.05% | ₹5,901 | 0.94% |
Moderately High
|
|
HDFC Banking & Financial Services Fund - Direct Plan
Sector
Direct
|
₹15.21 | 6.14% | 32.40% | 0.00% | ₹4,510 | 0.80% |
Very High
|
|
HDFC Banking & Financial Services Fund - Direct Plan
Sector
Direct
|
₹15.21 | 6.14% | 32.40% | 0.00% | ₹4,510 | 0.80% |
Very High
|
|
HDFC Housing Opportunities Fund - Direct Plan
Diversified
Direct
|
₹16.10 | 0.76% | 32.38% | 48.81% | ₹1,272 | 1.19% |
Very High
|
What is the current NAV of HDFC Pharma and Healthcare Fund Regular IDCW-Reinvestment?
What is the fund size (AUM) of HDFC Pharma and Healthcare Fund Regular IDCW-Reinvestment?
What are the historical returns of HDFC Pharma and Healthcare Fund Regular IDCW-Reinvestment?
What is the risk level of HDFC Pharma and Healthcare Fund Regular IDCW-Reinvestment?
What is the minimum investment amount for HDFC Pharma and Healthcare Fund Regular IDCW-Reinvestment?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article